Skip to main content
Erschienen in: Journal of Cancer Education 1/2019

03.08.2017

Training Needs of Clinical and Research Professionals to Optimize Minority Recruitment and Retention in Cancer Clinical Trials

verfasst von: Soumya J. Niranjan, Raegan W. Durant, Jennifer A. Wenzel, Elise D. Cook, Mona N. Fouad, Selwyn M. Vickers, Badrinath R. Konety, Sarah B. Rutland, Zachary R. Simoni, Michelle Y. Martin

Erschienen in: Journal of Cancer Education | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

The study of disparities in minority recruitment to cancer clinical trials has focused primarily on inquiries among minority patient populations. However, clinical trial recruitment is complex and requires a broader appreciation of the multiple factors that influence minority participation. One area that has received little attention is minority recruitment training for professionals who assume various roles in the clinical trial recruitment process. Therefore, we assessed the perspectives of cancer center clinical and research personnel on their training and education needs toward minority recruitment for cancer clinical trials. Ninety-one qualitative interviews were conducted at five U.S. cancer centers among four stakeholder groups: cancer center leaders, principal investigators, referring clinicians, and research staff. Interviews were recorded and transcribed. Qualitative analyses focused on response data related to training for minority recruitment for cancer clinical trials. Four prominent themes were identified: (1) Research personnel are not currently being trained to focus on recruitment and retention of minority populations; (2) Training for minority recruitment and retention provides for a specific focus on factors influencing minority research participation; (3) Training on cultural awareness may help to bridge cultural gaps between potential minority participants and research professionals; (4) Views differ regarding the importance of research personnel training designed to focus on recruitment of minority populations. There is a lack of systematic training for minority recruitment. Many stakeholders acknowledged the benefits of minority recruitment training and welcomed training that focuses on increasing cultural awareness to increase the participation of minorities in cancer clinical trials.
Literatur
1.
Zurück zum Zitat Health, U.D.o. and H. Services (1994) NIH guidelines on the inclusion of women and minorities as subjects in clinical research. Fed Regist 59(59):14508–14513 Health, U.D.o. and H. Services (1994) NIH guidelines on the inclusion of women and minorities as subjects in clinical research. Fed Regist 59(59):14508–14513
2.
Zurück zum Zitat Giuliano AR et al (2000) Participation of minorities in cancer research: the influence of structural, cultural, and linguistic factors. Ann Epidemiol 10(8):S22–S34CrossRef Giuliano AR et al (2000) Participation of minorities in cancer research: the influence of structural, cultural, and linguistic factors. Ann Epidemiol 10(8):S22–S34CrossRef
3.
Zurück zum Zitat Scalici J et al (2015) Minority participation in gynecologic oncology group (GOG) studies. Gynecol Oncol 138(2):441–444CrossRef Scalici J et al (2015) Minority participation in gynecologic oncology group (GOG) studies. Gynecol Oncol 138(2):441–444CrossRef
4.
Zurück zum Zitat Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66(1):7–30CrossRef Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66(1):7–30CrossRef
5.
Zurück zum Zitat DeSantis CE et al (2016) Breast cancer statistics, 2015: convergence of incidence rates between black and white women. CA Cancer J Clin 66(1):31–42CrossRef DeSantis CE et al (2016) Breast cancer statistics, 2015: convergence of incidence rates between black and white women. CA Cancer J Clin 66(1):31–42CrossRef
6.
Zurück zum Zitat Ford JG et al (2008) Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer 112(2):228–242CrossRef Ford JG et al (2008) Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer 112(2):228–242CrossRef
7.
Zurück zum Zitat Howerton MW et al (2007) Provider roles in the recruitment of underrepresented populations to cancer clinical trials. Cancer 109(3):465–476CrossRef Howerton MW et al (2007) Provider roles in the recruitment of underrepresented populations to cancer clinical trials. Cancer 109(3):465–476CrossRef
8.
Zurück zum Zitat Durant RW et al (2014) Perspectives on barriers and facilitators to minority recruitment for clinical trials among cancer center leaders, investigators, research staff, and referring clinicians: enhancing minority participation in clinical trials (EMPaCT). Cancer 120(S7):1097–1105CrossRef Durant RW et al (2014) Perspectives on barriers and facilitators to minority recruitment for clinical trials among cancer center leaders, investigators, research staff, and referring clinicians: enhancing minority participation in clinical trials (EMPaCT). Cancer 120(S7):1097–1105CrossRef
9.
Zurück zum Zitat Rivers D et al (2013) A systematic review of the factors influencing African Americans' participation in cancer clinical trials. Contemp Clin Trials 35(2):13–32CrossRef Rivers D et al (2013) A systematic review of the factors influencing African Americans' participation in cancer clinical trials. Contemp Clin Trials 35(2):13–32CrossRef
10.
Zurück zum Zitat Germino BB et al (2011) Engaging African American breast cancer survivors in an intervention trial: culture, responsiveness and community. J Cancer Surviv 5(1):82–91CrossRef Germino BB et al (2011) Engaging African American breast cancer survivors in an intervention trial: culture, responsiveness and community. J Cancer Surviv 5(1):82–91CrossRef
11.
Zurück zum Zitat Robins Sadler G et al (2006) Health parties for African American study recruitment. J Cancer Educ 21(2):71–76CrossRef Robins Sadler G et al (2006) Health parties for African American study recruitment. J Cancer Educ 21(2):71–76CrossRef
12.
Zurück zum Zitat Jones RA, Steeves R, Williams I (2009) Strategies for recruiting African American men into prostate cancer screening studies. Nurs Res 58(6):452CrossRef Jones RA, Steeves R, Williams I (2009) Strategies for recruiting African American men into prostate cancer screening studies. Nurs Res 58(6):452CrossRef
13.
Zurück zum Zitat Ford ME, Siminoff LA, Pickelsimer E, Mainous AG, Smith DW, Diaz VA, Soderstrom LH, Jefferson MS, Tilley BC (2013) Unequal burden of disease, unequal participation in clinical trials: solutions from African American and Latino community members. Health Soc Work 38(1):29–38 Ford ME, Siminoff LA, Pickelsimer E, Mainous AG, Smith DW, Diaz VA, Soderstrom LH, Jefferson MS, Tilley BC (2013) Unequal burden of disease, unequal participation in clinical trials: solutions from African American and Latino community members. Health Soc Work 38(1):29–38
14.
Zurück zum Zitat Ma GX, Tan Y, Blakeney NC, Seals BF, Ma XS, Zhai S, Liu A, Tai Y, Michaels M (2013) The impact of a community-based clinical trial educational intervention among underrepresented Chinese Americans. Cancer Epidemiol Biomark Prev 23(3):424–32 Ma GX, Tan Y, Blakeney NC, Seals BF, Ma XS, Zhai S, Liu A, Tai Y, Michaels M (2013) The impact of a community-based clinical trial educational intervention among underrepresented Chinese Americans. Cancer Epidemiol Biomark Prev 23(3):424–32
15.
Zurück zum Zitat Anwuri VV et al (2013) An institutional strategy to increase minority recruitment to therapeutic trials. Cancer Causes Control 24(10):1797–1809CrossRef Anwuri VV et al (2013) An institutional strategy to increase minority recruitment to therapeutic trials. Cancer Causes Control 24(10):1797–1809CrossRef
16.
Zurück zum Zitat Quinn GP et al (2011) Enhancing oncology health care provider's sensitivity to cultural communication to reduce cancer disparities: a pilot study. J Cancer Educ 26(2):322CrossRef Quinn GP et al (2011) Enhancing oncology health care provider's sensitivity to cultural communication to reduce cancer disparities: a pilot study. J Cancer Educ 26(2):322CrossRef
17.
Zurück zum Zitat Wallington SF et al (2016) Enrolling minority and underserved populations in cancer clinical research. Am J Prev Med 50(1):111–117CrossRef Wallington SF et al (2016) Enrolling minority and underserved populations in cancer clinical research. Am J Prev Med 50(1):111–117CrossRef
18.
Zurück zum Zitat Betancourt JR et al (2003) Defining cultural competence: a practical framework for addressing racial/ethnic disparities in health and health care. Public Health Rep 118(4):293–302CrossRef Betancourt JR et al (2003) Defining cultural competence: a practical framework for addressing racial/ethnic disparities in health and health care. Public Health Rep 118(4):293–302CrossRef
19.
Zurück zum Zitat Smith WR et al (2007) Recommendations for teaching about racial and ethnic disparities in health and health care. Ann Intern Med 147(9):654–664CrossRef Smith WR et al (2007) Recommendations for teaching about racial and ethnic disparities in health and health care. Ann Intern Med 147(9):654–664CrossRef
20.
Zurück zum Zitat Association, W.M (2015) WMA declaration of Geneva. Int J Person Cent Med 4(3):157 Association, W.M (2015) WMA declaration of Geneva. Int J Person Cent Med 4(3):157
21.
Zurück zum Zitat Nelson AR, AY Stith, and BD Smedley (2003) Unequal treatment: confronting racial and ethnic disparities in health care (full printed version). National Academies Press, Washington Nelson AR, AY Stith, and BD Smedley (2003) Unequal treatment: confronting racial and ethnic disparities in health care (full printed version). National Academies Press, Washington
22.
Zurück zum Zitat Abernethy A et al (2014) Turning the tide against cancer through sustained medical innovation: the pathway to progress. Clin Cancer Res 20(5):1081–1086CrossRef Abernethy A et al (2014) Turning the tide against cancer through sustained medical innovation: the pathway to progress. Clin Cancer Res 20(5):1081–1086CrossRef
23.
Zurück zum Zitat Bergenmar M, Johansson H, Wilking N (2011) Levels of knowledge and perceived understanding among participants in cancer clinical trials–factors related to the informed consent procedure. Clin Trials 8(1):77–84CrossRef Bergenmar M, Johansson H, Wilking N (2011) Levels of knowledge and perceived understanding among participants in cancer clinical trials–factors related to the informed consent procedure. Clin Trials 8(1):77–84CrossRef
24.
Zurück zum Zitat Albrecht TL et al (2008) Influence of clinical communication on patients' decision making on participation in clinical trials. J Clin Oncol 26(16):2666–2673CrossRef Albrecht TL et al (2008) Influence of clinical communication on patients' decision making on participation in clinical trials. J Clin Oncol 26(16):2666–2673CrossRef
25.
Zurück zum Zitat Durant RW et al (2011) Different types of distrust in clinical research among whites and African Americans. J Natl Med Assoc 103(2):123–130CrossRef Durant RW et al (2011) Different types of distrust in clinical research among whites and African Americans. J Natl Med Assoc 103(2):123–130CrossRef
Metadaten
Titel
Training Needs of Clinical and Research Professionals to Optimize Minority Recruitment and Retention in Cancer Clinical Trials
verfasst von
Soumya J. Niranjan
Raegan W. Durant
Jennifer A. Wenzel
Elise D. Cook
Mona N. Fouad
Selwyn M. Vickers
Badrinath R. Konety
Sarah B. Rutland
Zachary R. Simoni
Michelle Y. Martin
Publikationsdatum
03.08.2017
Verlag
Springer US
Erschienen in
Journal of Cancer Education / Ausgabe 1/2019
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-017-1261-0

Weitere Artikel der Ausgabe 1/2019

Journal of Cancer Education 1/2019 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.